Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway
The presented low use of SACT at EOL has been achieved in a population where good survival has been documented. Patients with poor performance status and older age received less SACT than patients with good performance status and younger age.
Authors
- Kathinka Schmidt Slørdahl (ORCID: https://orcid.org/0000-0002-0538-4977)
- Nina Helbekkmo (ORCID: https://orcid.org/0000-0003-4748-4914)
- Yngvar Nilssen (ORCID: https://orcid.org/0000-0002-3620-1555)
- Steinar Solberg (ORCID: https://orcid.org/0000-0002-8206-5435)
- Odd Terje Brustugun (ORCID: https://orcid.org/0000-0002-5153-8391)
- Åslaug Helland (ORCID: https://orcid.org/0000-0002-5520-0275)
- Marianne Aanerud (ORCID: https://orcid.org/0000-0003-1337-7440)
- Bjørn Henning Grønberg (ORCID: https://orcid.org/0000-0001-5744-1534)
Institutions
- Oslo University Hospital (NO)
- University Hospital of North Norway (NO)
- Norwegian Institute of Public Health (NO)
- University of Oslo (NO)
- Norwegian University of Science and Technology (NO)
- Vestre Viken Hospital Trust (NO)
- Haukeland University Hospital (NO)
- St Olav's University Hospital (NO)
- Cancer Registry of Norway (NO)
- University of Bergen (NO)
Publication Details
- Journal
- BJC Reports
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1038/s44276-025-00183-w
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00